Avotaciclib trihydrochloride
Modify Date: 2024-01-09 20:40:52
Avotaciclib trihydrochloride structure
|
Common Name | Avotaciclib trihydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1983984-01-5 | Molecular Weight | 390.66 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H14Cl3N7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Avotaciclib trihydrochlorideAvotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreatic cancer[1]. |
| Name | Avotaciclib trihydrochloride |
|---|
| Description | Avotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreatic cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK1 |
| References |
| Molecular Formula | C13H14Cl3N7O |
|---|---|
| Molecular Weight | 390.66 |